Pharmacotherapy of dementia

被引：0
作者：
Pavlovic, Dragan M. [1 ]
Pavlovic, Aleksandra M. [1 ]
Totic, Sanja [2 ]
机构：
[1] Klin Ctr Srbije, Inst Neurol, Belgrade 11000, Serbia
[2] Klin Ctr Srbije, Inst Psihijatriju, Belgrade 11000, Serbia
来源：
VOJNOSANITETSKI PREGLED | 2010年 / 67卷 / 05期
关键词：
dementia; drug therapy; treatment outcome; MODERATE ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; DOUBLE-BLIND; THERAPY; SAFETY; TRIAL; BETA; INFLAMMATION; INHIBITOR; MEMANTINE;
D O I：
10.2298/VSP1005419P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：419 / 426
页数：8
相关论文
共 50 条
  • [21] Pharmacotherapy for overactive bladder syndrome and the risk of incident dementia
    Sheyn, David
    Murphy, Jennifer
    Mahajan, Abhimanyu
    Bretschneider, C. Emi
    Scott, Lindsay
    Rhodes, Stephen
    Hijaz, Adonis
    Gupta, Ankita
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
  • [22] Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)
    Wittebrood, Casper
    Boban, Marina
    Cagnin, Annchiara
    Capellari, Sabina
    De Winter, Francois-Laurent
    Djamshidian, Atbin
    Gonzalez, Manuel Menendez
    Hjermind, Lena E.
    Krajcovicova, Lenka
    Kruger, Johanna
    Levin, Johannes
    Reetz, Kathrin
    Rodriguez, Eloy Rodriguez
    Rohrer, Jonathan
    Van Langenhove, Tim
    Reinhard, Carola
    Graessner, Holm
    Rusina, Robert
    Saracino, Dario
    Houot, Marion
    Seelar, Harro
    Vandenberghe, Rik
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (12)
  • [23] Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors
    Bergert, F. W.
    Conrad, D.
    Ehrenthal, K.
    Fessler, J.
    Gross, J.
    Gundermann, K.
    Kluthe, B.
    Heinrich, W. Lang
    Liesenfeld, A.
    Loew, P. G.
    Luther, E.
    Pchalek, R.
    Seffrin, J.
    Sterzing, A.
    Wolfring, H. -J.
    Zimmermann, U.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (01) : 11 - 22
  • [24] Efficacy of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A protocol for systematic review and meta-analysis
    Boongird, Chitima
    Tearneukit, Worapong
    Wongpipathpong, Wannisa
    McKay, Gareth J.
    Thakkinstian, Ammarin
    MEDICINE, 2022, 101 (50)
  • [25] Guidelines on “pharmacotherapy of neurodegenerative dementia”: An update; [Leitlinien zur „Pharmakotherapie neurodegenerativer Demenzen“: Ein Update]
    Fassbender K.
    Frölich L.
    Der Nervenarzt, 2014, 85 (12) : 1589 - 1602
  • [26] Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
    Cummings, Jeffrey L.
    Tong, Gary
    Ballard, Clive
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (03) : 779 - 794
  • [27] Antipsychotic Drugs Predominate in Pharmacotherapy of Nursing Home Residents with Dementia
    Huber, M.
    Koelzsch, M.
    Rapp, M. A.
    Wulff, I.
    Kalinowski, S.
    Bolbrinker, J.
    Hofmann, W.
    Scholze, J.
    Draeger, D.
    Kreutz, R.
    PHARMACOPSYCHIATRY, 2012, 45 (05) : 182 - 188
  • [28] Pharmacotherapy of dementia in Germany: Results from a nationwide claims database
    Bohlken, Jens
    Schulz, Mandy
    Rapp, Michael A.
    Baetzing-Feigenbaum, Joerg
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (12) : 2333 - 2338
  • [29] Use of memantine for the treatment of dementia
    Lo, Daphne
    Grossberg, George T.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (10) : 1359 - 1370
  • [30] Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine
    Wong, Chit Wai
    DRUGS & AGING, 2016, 33 (07) : 451 - 460
12345